Allena Pharmaceuticals
ALNA
ALNA was delisted on the 7th of September, 2022.
28 hedge funds and large institutions have $23.6M invested in Allena Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
49% more capital invested
Capital invested by funds: $15.9M → $23.6M (+$7.76M)
17% more funds holding
Funds holding: 24 → 28 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.58M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$382K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$376K |
| 5 |
Renaissance Technologies
New York
|
+$344K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$329K |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$225K |
| 3 |
Goldman Sachs
New York
|
-$77.5K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$36K |
| 5 |
Jane Street
New York
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $4K | -$3.49K | -2,500 | -46% |
|
27
Wells Fargo
San Francisco,
California
| $1K | +$120 | +86 | +8% |
|
|
28
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$329K | -222,381 | Closed |
|
|
WS
29
Wedbush Securities
Los Angeles,
California
| – | -$36K | -24,150 | Closed |
|
|
30
Jane Street
New York
| – | -$22K | -15,011 | Closed |
|
ALNA Hedge Fund Activity: Q4 2020 in Review
28 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q4 2020, worth a combined $23.6M — up 49% from $15.9M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ALNA positions and 4 closed out — a net gain of 4 holders — while 9 added to existing stakes and 6 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $5.58M. The largest seller was Jacobs Levy Equity Management, exiting entirely with an estimated $329K sold.
- 28 institutional investors held Allena Pharmaceuticals (ALNA) as of Q4 2020, up from 24 in Q3 2020.
- Funds reported $23.6M of Allena Pharmaceuticals stock for Q4 2020, up 49% quarter-over-quarter.
- 8 funds opened new Allena Pharmaceuticals positions in Q4 2020 and 4 closed out, a net change of +4 holders.
- The largest Allena Pharmaceuticals buyer in Q4 2020 was Point72 Asset Management, an estimated $5.58M added.
- The largest Allena Pharmaceuticals seller in Q4 2020 was Jacobs Levy Equity Management, an estimated $329K sold.
Based on aggregated 13F filings for Q4 2020.